On 3 November 2021, the application filed by Canature Health Technology Group Co., Ltd. (“Canature”, 300272.SZ) for registering its issue of shares to specific target was passed and approved by China Securities Regulatory Commission.

Canature intends to raise the fund no less than RMB 100,000,000 but no more than RMB 150,000,000 by issuing shares to specific targets to repay its debts and supplement the working capital.  The company is a one-stop solution provider of global water treatment products.  Its products are marketed in more than 100 countries and regions around the world. 

Grandall Shanghai Office has been retained as Canature’s special legal counsel in this project, with LIU Wei, LIN Zhen, and JIN Yu as key lawyers serving the case.